Mohammad Etminan, MD
Orthopaedic Surgery of the Spine · Richmond, TXNPI 1972509230
Payments from drug & device makers
Across 129 payments — averaging $7839.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corelink, LLC$541K
- Zavation Medical Products, LLC$311K
- Alphatec Spine, Inc$154K
- Johnson & Johnson$2K
- Medtronic$658
- Spineart USA Inc$630
- plus $3K from 19 others
What the payments were for
- Royalty or licence$873,27486%
- Consulting fees$130,00013%
- Travel & lodging$4920%
- Food & beverage$7,4801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corelink, LLC | 12 | $540,501 |
| Zavation Medical Products, LLC | 32 | $310,558 |
| Alphatec Spine, Inc | 27 | $153,924 |
| Johnson & Johnson | 16 | $1,515 |
| Medtronic(2 entities) | 6 | $658 |
| Spineart USA Inc | 2 | $630 |
| Cerapedics Inc. | 3 | $444 |
| Providence Medical Technology, Inc. | 4 | $410 |
| Medinc Of Texas | 3 | $409 |
| Relievant Medsystems, Inc. | 2 | $313 |
| Arthrex | 6 | $303 |
| Innovasis Inc | 1 | $284 |
| Globus Medical | 2 | $231 |
| Si-bone, Inc. | 2 | $178 |
| Centinel Spine, LLC | 1 | $140 |
| Kuros Biosciences USA, Inc | 1 | $124 |
| Davol Inc. | 1 | $118 |
| Zimvie Inc. | 1 | $114 |
| Novapproach Spine, LLC | 1 | $111 |
| Surgalign Spine Technologies, Inc. | 1 | $105 |
| Intrinsic Therapeutics | 1 | $85 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Zimmer Biomet | 1 | $29 |
| Abbott | 1 | $24 |
| Arteriocyte Medical Systems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BATALLION LATERAL$84,374
- BATTALION LLIF$65,997
- Other - Miscellaneous$2,847
- SYMPHONY$767
- Intracept$625
- EXPEDIUM$503
- MAZOR X SYSTEM$452
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$444
- CONDUIT$347
- Sentio$237
- BASE$231
- INVICTUS OPEN$200
- OsseoScrew$171
- PRODISC C VIVO$140
- Teligen$133
- VIPER$132
- SYNFIX$124
- ARISTA AH FLEXITIP$118
- COHERE$117
- Bendini$117
How this compares
$1,011,246 in reported general payments places this provider in the 90th percentile of 207 orthopaedic surgery of the spine providers in Texas.
See all orthopaedic surgery of the spine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 156 | $1,421 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 36 | $443 |
| Tramadol Hcl | 46 | $157 |
| Celecoxib | 17 | $133 |
| Methylprednisolone | 14 | $114 |
| Meloxicam | 17 | $51 |
| Tizanidine Hcl | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Richmond
- Randall DryerAustin$2.9M
- Craig KuhnsAustin$2.7M
- David WimberleyHouston$2.2M
- Jeffrey PhelpsNorth Richland Hills$1.9M
- Eric WieserArlington$1.5M
- Richard GuyerPlano$1.3M
- Andrew ClavennaDallas$1.3M
- Ivan ChengKyle$1.2M
- Stephen TolhurstFlower Mound$1.1M
- Michael ObrienPlano$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.